> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Sponsoring Liver Injury, Dysfunction Conference
- URL: https://www.fdaweb.com/fda-sponsoring-liver-injury-dysfunction-conference/
- Published: 2016-01-14T12:00:00.000Z
- Updated: 2026-09-15T02:27:47.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5134431

> FDA and the Critical Path Institute are co-sponsoring a 3/23-24 public conference on “How Should Liver Injury and Dysfunction Caused by Drugs Be Measured, Evaluated, and Acted Upon in Clinical Trials?” A *Federal Register* [notice](https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-00690.pdf?ref=fdaweb.com) says the conference’s purpose is to discuss, debate, and share views among stakeholders in academia, patient groups, regulatory bodies, and the healthcare and drug industries on how best to measure, evaluate, and act upon liver injury and dysfunction caused by clinical trial drugs.  
>  
> The conference builds on a 2009 guidance, *Drug-Induced Liver Injury: Premarketing Clinical Evaluation*.